Boston Scientific Corp. received CE mark and began the European commercial launch of its new 25 mm Lotus transcatheter aortic valve implantation (TAVI) System, complementing the currently available 23 mm and 27 mm valve sizes.

The Children's Hospital of Philadelphia (CHOP) launched the Fetal Neuroprotection and Neuroplasticity Program. 

cardiac ultrasound, FOCUS exam

July 17 2014 — The Journal of the American Society of Echocardiography (JASE) announced the publication of a new consensus statement on the use of focused cardiac ultrasound (FoCUS) in its July 2014 issue.

A study by researchers at CVS Caremark, Aetna and Brigham and Women’s Hospital published in the May issue of Health Affairs, finds that eliminating copays for preventive medications prescribed for post-heart attack patients, can significantly improve medication adherence and health outcomes for non-white patients. 

CorMatrix Cardiovascular and the Central Clinical Hospital of the Ministry of Interior in Warsaw (Centralny Szpital Kliniczny MSW) of Warsaw, Poland, announced the successful enrollment and treatment of five patients in the first ever study evaluating the CorMatrix ECM delivered trans-epicardially for the improvement of myocardial function in patients at risk or suffering from congestive heart failure (CHF).

A new physician poster presentation at the Atrial Fibrillation Symposium 19th Annual International Meeting in Orlando, Fla., reports long-term outcomes for the convergent procedure, a multidisciplinary epicardial-endocardial approach to treat patients with persistent atrial fibrillation (AF)

Each year, deep vein thrombosis (DVT) leads to hospitalization for approximately 250,000 Americans, and often leads to serious — and even fatal —complications. Fortunately, at the California Institute for Deep Venous Thrombosis, those suffering from the effects of thrombosis will find an effective DVT treatment from Farshad Malekmehr.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now